Showing results (1921-1930 of 5,502) with videos related to

Sort By:
Pageof 551
Inflammatory Bowel Diseases|August 19, 2006
Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humansSoichiro Kayo, Yoshihiro Ikura, Takehisa Suekane, et al.
Inflammatory Bowel Diseases|August 19, 2006
Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's diseaseMay Fakhoury, Julien Lecordier, Yves Medard, et al.
Inflammatory Bowel Diseases|August 19, 2006
A defect in epithelial barrier integrity is not required for a systemic response to bacterial antigens or intestinal injury in T cell receptor-alpha gene-deficient miceBeate C Sydora, Michele M Tavernini, Jason Doyle, et al.
Inflammatory Bowel Diseases|February 17, 2007
Safety of biologic therapyWojciech Blonski, Gary R Lichtenstein
Inflammatory Bowel Diseases|March 28, 2007
Beta-defensin production by human colonic plasma cells: a new look at plasma cells in ulcerative colitisArman Rahman, Anna Fahlgren, Basel Sitohy, et al.
Inflammatory Bowel Diseases|February 8, 2007
Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern EuropeJ Van Limbergen, R K Russell, E R Nimmo, et al.
Inflammatory Bowel Diseases|February 8, 2007
Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytesTaku Kobayashi, Susumu Okamoto, Yuko Iwakami, et al.
Inflammatory Bowel Diseases|February 8, 2007
Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesisShigeo Yoshizawa, Katsuyoshi Matsuoka, Nagamu Inoue, et al.
Inflammatory Bowel Diseases|January 9, 2007
Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapyCarsten Schmidt, Thomas Giese, Eva Hermann, et al.
Inflammatory Bowel Diseases|January 9, 2007
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's diseaseJulia Dambacher, Tanja Staudinger, Julia Seiderer, et al.
Pageof 551